University of Alabama Birmingham
Mechanism Of Targeted Cancer Therapeutics-Induced Cardiotoxicity
Abstract
dc:description.abstractTargeted cancer therapies are known to cause cardiovascular (CV) complications in human patients. Agents such as osimertinib, a tyrosine kinase inhibitor (TKI), as well as immune checkpoint inhibitors (ICIs) have been demonstrated to induce severe cardiotoxicities, including heart failure and myocarditis. Nevertheless, the mechanisms of TKIs and ICIs-induced cardiotoxicity remain poorly understood. Herein, we developed the first in vivo preclinical model of osimertinib-induced cardiotoxicity using a transverse aortic constriction (TAC) mouse model. Osimertinib-treated mice displayed severe cardiac dysfunction, elevated markers of heart failure and fibrosis, and failed to undergo compensatory hypertrophic remodeling, resulting in cardiomyocyte death. Mechanistically, we identified suppression of ERK/AKT prosurvival signaling, mitochondrial dysfunction, and activation of Bax/Bcl-xl apoptosis pathway. FDA-approved HDAC inhibitor Vorinostat (SAHA), restored cardiac function and cell survival while improving osimertinib’s efficacy in non-small cell lung cancer (NSCLC)-derived PC9 cells. In a separate set of studies, we examined ICIs-associated myocarditis employing a myeloid-specific programmed death-ligand (PD-L1) knockout (KO) mice. Deletion of PD-L1 led to early-onset cardiac dysfunction, systemic inflammation, increased infiltration of CCR2+ pro-inflammatory macrophages, and enhanced T cell activation, revealing a critical immunoregulatory role for myeloid PD-L1 in maintaining cardiac homeostasis. Our findings define the mechanisms of cardiotoxicity induced by targeted therapies and highlight histone deacetylase (HDAC) inhibitions and myeloid-specific immune modulation as potential targeted strategies to mitigate treatment-related cardiac events.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (PhD)
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Cellular and Molecular Physiology
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Toro-Cora, Angelica
- Contributors dc:contributor
-
- <p>Hind Lal</p>
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.library.uab.edu/etd-collection/7339